The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
Open accessAbstract
G protein–coupled receptor (GPCR) oligomers have been proposed to play critical roles in cell signaling, but confirmation of their existence in a native context remains elusive, as no direct interactions between receptors have been reported. To demonstrate their presence in native tissues, we developed a time-resolved FRET strategy that is based on receptor labeling with selective fluorescent ligands. Specific FRET signals were observed with four different receptors expressed in cell lines, consistent with their dimeric or oligomeric nature in these transfected cells. More notably, the comparison between FRET signals measured with sets of fluorescent agonists and antagonists was consistent with an asymmetric relationship of the two protomers in an activated GPCR dimer. Finally, we applied the strategy to native tissues and succeeded in demonstrating the presence of oxytocin receptor dimers and/or oligomers in mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Maurel, D., Comps-Agrar, L., Brock, C., Rives, M.-L., Bourrier, E., Ayoub, M. A., Bazin, H., Tinel, N., Durroux, T., Prézeau, L., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1213 · Cited by 505
Self-citationBuilding a new conceptual framework for receptor heteromers
Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxe, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 394
Self-citationA role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 388
A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers
Waldhoer, M., Fong, J., Jones, R. M., Lunzer, M. M., Sharma, S. K., Kostenis, E., Portoghese, P. S., & Whistler, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501112102 · Cited by 347
Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation
Han, Y., Moreira, I. S., Urizar, E., Weinstein, H., & Javitch, J. A. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.199 · Cited by 339
Self-citationMathis, G. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.9.1391 · Cited by 339
Dopamine D2 receptors form higher order oligomers at physiological expression levels
Guo, W., Urizar, E., Kralikova, M., Mobarec, J. C., Shi, L., Filizola, M., & Javitch, J. A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.153 · Cited by 335
Self-citationTerrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 322
Self-citationLuminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer.
Selvin, P. R., & Hearst, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10024 · Cited by 299
Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P.-Y., Roerig, S. C., & Portoghese, P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506627102 · Cited by 297
Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity
Urizar, E., Montanelli, L., Loy, T., Bonomi, M., Swillens, S., Gales, C., Bouvier, M., Smits, G., Vassart, G., & Costagliola, S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600686 · Cited by 295
The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer
Guo, W., Shi, L., & Javitch, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200679200 · Cited by 293
Self-citationStructure of the rhodopsin dimer: a working model for G-protein-coupled receptors
Fotiadis, D., Jastrzebska, B., Philippsen, A., Müller, D. J., Palczewski, K., & Engel, A. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.03.013 · Cited by 273
Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling
Vilardaga, J.-P., Nikolaev, V. O., Lorenz, K., Ferrandon, S., Zhuang, Z., & Lohse, M. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.64 · Cited by 264
Barki-Harrington, L., Luttrell, L. M., & Rockman, H. A. (2003) · Circulation · doi:10.1161/01.cir.0000092166.30360.78 · Cited by 252
Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells
Patel, R. C., Kumar, U., Lamb, D. C., Eid, J. S., Rocheville, M., Grant, M., Rani, A., Hazlett, T., Patel, S. C., Gratton, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042705099 · Cited by 190
Ciruela, F., Escriche, M., Burgueño, J., Angulo, E., Casadó, V., Soloviev, M. M., Canela, E. I., Mallol, J., Chan, W.-Y., Lluis, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006960200 · Cited by 180
Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors
Wreggett, K. A., & Wells, J. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22488 · Cited by 174
Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR
Hlavackova, V., Goudet, C., Kniazeff, J., Zikova, A., Maurel, D., Vol, C., Trojanova, J., Prézeau, L., Pin, J., & Blahos, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600557 · Cited by 165
Self-citationBazin, H., Trinquet, E., & Mathis, G. (2002) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00040-x · Cited by 164
Self-citationHetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists
Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., Javitch, J. A., Parmentier, M., & Springael, J.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054809 · Cited by 163
Self-citationHague, C., Uberti, M. A., Chen, Z., Hall, R. A., & Minneman, K. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314014200 · Cited by 162
Asymmetric conformational changes in a GPCR dimer controlled by G‐proteins
Damian, M., Martin, A., Mesnier, D., Pin, J., & Banères, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601449 · Cited by 145
Self-citationSpringael, J., Minh, P. N. L., Urizar, E., Costagliola, S., Vassart, G., & Parmentier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019414 · Cited by 137
Goudet, C., Kniazeff, J., Hlaváčková, V., Malhaire, F., Maurel, D., Acher, F., Blahoš, J., Prézeau, L., & Pin, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502642200 · Cited by 133
Self-citationCrosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration
Rives, M., Vol, C., Fukazawa, Y., Tinel, N., Trinquet, E., Ayoub, M. A., Shigemoto, R., Pin, J., & Prézeau, L. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.177 · Cited by 133
Self-citationDopamine D2 Receptor Dimer Formation
Armstrong, D., & Strange, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006936200 · Cited by 120
Chini, B., Mouillac, B., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., & Barberis, C. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01135-0 · Cited by 117
Self-citationDimerization of chemokine receptors and its functional consequences
Springael, J., Urizar, E., & Parmentier, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.005 · Cited by 111
The apparent cooperativity of some GPCRs does not necessarily imply dimerization
Chabre, M., Déterre, P., & Antonny, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.003 · Cited by 110
Albizu, L., Balestre, M., Breton, C., Pin, J., Manning, M., Mouillac, B., Barberis, C., & Durroux, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025684 · Cited by 108
Self-citationThe Ants Go Marching Two by Two: Oligomeric Structure of G-Protein-Coupled Receptors
Javitch, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006320 · Cited by 97
Self-citationCardiac Muscarinic Receptors. Cooperativity as the Basis for Multiple States of Affinity
Chidiac, P., Green, M. A., Pawagi, A. B., & Wells, J. W. (1997) · Biochemistry · doi:10.1021/bi961939t · Cited by 92
Durroux, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.006 · Cited by 83
Self-citationクリプテート発光の時間分解増幅 生物分子相互作用を追跡するための多才な技術 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター
Bazin, H., Trinquet, E., & Mathis, G. R. (2002) · Cited by 81
Self-citationde la Cotte, N., Balestre, M., Phalipou, S., Hibert, M., Manning, M., Barberis, C., & Mouillac, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29462 · Cited by 72
Self-citationAlbizu, L., Teppaz, G., Seyer, R., Bazin, H., Ansanay, H., Manning, M., Mouillac, B., & Durroux, T. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061404q · Cited by 64
Self-citationPhalipou, S., de la Cotte, N., Carnazzi, E., Seyer, R., Mahé, E., Jard, S., Barberis, C., & Mouillac, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26536 · Cited by 62
Self-citationBreton, C., Chellil, H., Kabbaj-Benmansour, M., Carnazzi, E., Seyer, R., Phalipou, S., Morin, D., Durroux, T., Zingg, H. H., Barberis, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102073200 · Cited by 60
Self-citationCottet, M., Albizu, L., Perkovska, S., Jean‐Alphonse, F., Rahmeh, R., Orcel, H., Méjean, C., Granier, S., Mendre, C., Mouillac, B., et al. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.003 · Cited by 54
Self-citationTerrillon, S., Cheng, L., Stoev, S. B., Mouillac, B., Barberis, C., Manning, M., & Durroux, T. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010526+ · Cited by 51
Self-citationInvestigation of Cooperativity in the Binding of Ligands to the D2 Dopamine Receptor
Vivó, M., Lin, H., & Strange, P. G. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012443 · Cited by 44
Devost, D., & Zingg, H. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310461 · Cited by 41
Mouillac, B., Manning, M., & Durroux, T. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708785740607 · Cited by 34
Self-citationFluorescent Pseudo-Peptide Linear Vasopressin Antagonists: Design, Synthesis, and Applications,
Durroux, T., Peter, M., Turcatti, G., Chollet, A., Balestre, M., Barberis, C., & Seyer, R. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9804782 · Cited by 31
Self-citationChristopoulos, A., Lanzafame, A. A., Ziegler, A., et al. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00814-3 · Cited by 28
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463
Gal, C. S., Raufaste, D., Double-Cazanave, E., Guillon, G., Garcia, C., Pascal, M., & Maffrand, J. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00322.x · Cited by 25
Mapping Peptide Antagonist Binding Sites of the Human V1a and V2 Vasopressin Receptors
Mouillac, B., Phalipou, S., de la Cotte, N., Balestre, M., Hibert, M., Manning, M., & Barberis, C. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_45 · Cited by 6
Self-citation
Cited by
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J.-P., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 570
Self-citationDopamine receptors –IUPHAR R eview 13
Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 521
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
Self-citationVasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
O'Carroll, A.-M., Lolait, S. J., Harris, L. E., & Pope, G. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0227 · Cited by 344
Metadata
- Authors
- Albizu, L., Cottet, M., Kralikova, M., Stoev, S., Seyer, R., Brabet, I., Roux, T., Bazin, H., Bourrier, E., Lamarque, L., Breton, C., Rives, M.-L., Newman, A., Javitch, J., Trinquet, E., Manning, M., Pin, J.-P., Mouillac, B., & Durroux, T.
- Venue
- Nature Chemical Biology
- Published
- 2010-07-11
- Volume
- 6
- Issue
- 8
- Pages
- 587-594
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W1971256251
- Cited by
- 340
- References
- 50
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.